ABOUT US

88fa0b_148214f77d5d4e459bbde6d8c2455e2cf

ABOUT US

hemotune AG

hemotune AG is a spin-off company originating out of the Functional Materials Lab at ETH Zurich. hemotune was founded in 2017 and so far raised more than CHF 10 million of funds since incorporation.

Vision

We envision a future where precision blood purification is an indispensable tool to improve patient outcomes and save lives in critical illness and beyond.

Mission

Our mission is to develop breakthrough blood purification technology, enabling revolutionary intervention strategies for the most urgent medical needs and making them accessible for the benefit of patients.

 

MEET THE TEAM

Dr. Inga Nilsson

R&D Chemist

Dr. Monika Dengler

Biomedical Scientist

Lukas Huber

Chemical Process Engineer

 
Dr. Ursina Haltinner

Head of Regulatory & Quality Affairs 

Dr. Martin Dinkel

Head of Clinical Affairs

Dr. Manuel Baumgartner

R&D Engineer

Lukas Langenegger

CEO

Dr. Carlos Mora

CSO

Dr. Jean-Claude Metzger

Head of Product Development

Anna Stocker

R&D Scientist

Rafael Schönenberger

Senior FW Developer

Lorenz Poiger

R&D Engineer

Aleksander Aid

Mechanical Engineering Intern

Dr. Sarah Keller

R&D Chemist

Katarzyna Nowak

R&D Software Engineer

BOARD OF DIRECTORS

Didier Cowling

President of the Board

Perry van Rijsingen

Board Member

 
Lukas Langenegger

CEO & Board Member

Dr. Carlos Mora

CSO & Board Member

Agnieszka Bor

Administrative Assistant

ADVISORS

Prof. Dr. Wendelin Jan Stark

Ph.D., ETH Zurich

Prof. Dr. Robert Grass

Ph.D., Turbobeads GmbH

Prof. Dr. Inge Herrmann

Ph.D., Empa & ETH Zurich

 
INVESTORS
Show More
Invest in a life-saving therapy.

You want to know more about our innovation?

© 2021 by hemotune

  • Black LinkedIn Icon
  • Black Twitter Icon
  • YouTube

created by wyssraumdesign